BioNTX Announces 2024 Tech Transfer Showcase Finalists Pitch Competition at the 2024 iC³ Life Science & Healthcare Innovation Summit
26 sept. 2024 10h00 HE
|
BioNTX
ARLINGTON, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- BioNTX is pleased to announce the finalists for the 3rd Annual Tech Transfer Showcase, set for Friday, October 4th, at the 2024 iC³ Life Science...
Lumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024
25 sept. 2024 16h05 HE
|
Lumos Pharma, Inc.
AUSTIN, Texas, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that an...
Automated and Closed Cell Therapy Market Research 2024-2029 Featuring Leading Players - Danaher, Thermo Fischer Scientific, Lonza, and Sartorius
24 sept. 2024 09h22 HE
|
Research and Markets
Dublin, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Automated and Closed Cell Therapy Market 2024-2029" report has been added to ResearchAndMarkets.com's offering. In 2023, the global market...
Consumer Healthcare Market Size is Projected to Reach USD 575.40 Billion by 2032, Growing at a CAGR of 7.51%: Straits Research
24 sept. 2024 09h10 HE
|
Straits Research Private Limited - Garner Insights
New York, United States, Sept. 24, 2024 (GLOBE NEWSWIRE) -- As per the Latest Report by Straits Research, The global consumer healthcare market size was valued at USD 303.37 billion in 2023 and is...
Life Sciences Week 2024: Advancing Innovation, Investment, and Collaboration in Alberta’s Life Sciences Sector
23 sept. 2024 13h10 HE
|
Applied Pharmaceutical Innovation (API)
Life Sciences Week, Alberta’s flagship event for showcasing the life sciences sector returns from September 23 to 27, 2024.
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366
23 sept. 2024 08h00 HE
|
Assembly Biosciences, Inc.
– ABI-5366 was well-tolerated, with a favorable safety profile observed with exposure of up to 70 days – – Half-life of approximately 20 days supports once-weekly or once-monthly oral dosing; both...
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement
23 sept. 2024 08h00 HE
|
European Microbiome Innovation for Health
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement Paris, France, September 23, 2024, 2:00 pm CET - The European Microbiome...
BioSyent Announces Agreement to Purchase Tibelia® (tibolone) Assets
20 sept. 2024 09h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Sept. 20, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc., has...
UAE Pharmaceuticals Market, By Region, Competition, Forecast and Opportunities, 2029F
20 sept. 2024 04h53 HE
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "UAE Pharmaceuticals Market, By Region, Competition, Forecast and Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's...
Western Blotting Market Is Expected To Generate Revenue Of USD 2,620.2 Mn By 2033, At 6.8% CAGR: Dimension Market Research.
18 sept. 2024 12h15 HE
|
Dimension Market Research
New York, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Overview The Global Western Blotting Market is expected to reach USD 1,455.4 million in 2024 which is further projected to grow up to USD 2,620.2...